Broadridge Reports Results for the Second Quarter and First Six Months of Fiscal Year 2017
Feb 08, 2017 12:02 pm UTC| Business
Second Quarter recurring fee revenue growth driven by acquisition of NACC and 6% organic growth Record second quarter Closed sales up 15% Reaffirming guidance for recurring fee revenues, Adjusted EPS and Closed sales;...
Broadridge Reports Results for the Second Quarter and First Six Months of Fiscal Year 2017
Feb 08, 2017 12:02 pm UTC| Business
Second Quarter recurring fee revenue growth driven by acquisition of NACC and 6% organic growth Record second quarter Closed sales up 15% Reaffirming guidance for recurring fee revenues, Adjusted EPS and Closed sales;...
Feb 08, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 08, 2017 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect recently purchased $136 million of first lien senior secured floating rate notes issued by Centerfield...
Feb 08, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 08, 2017 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect recently purchased $136 million of first lien senior secured floating rate notes issued by Centerfield...
New 3-D Seismic Data Identifies Significant Reserve Potential
Feb 08, 2017 12:01 pm UTC| Business
New York, Feb. 08, 2017 -- Petro River Oil Corp. (OTCBB: PTRC) (“Petro River” or the “Company”), an independent oil and gas exploration company utilizing the latest 3-D seismic technology, announced today that recently...
Plug Power Ships First Production Progen Engines for Electric Vehicle Range Extenders
Feb 08, 2017 12:01 pm UTC| Business
LATHAM, N.Y., Feb. 08, 2017 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, has shipped the first production ProGen fuel cell engines for use in electric...
Apricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference
Feb 08, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 08, 2017 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer,...